Diagnosis and management of nausea and vomiting in pregnancy

Fetal and Maternal Medicine Review

Volumn 17, Issue 1, 2006, Pages 45-67

  Magee, Laura ^a,b,d   Shrim, Alon ^c   Koren, Gideon ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BENDECTIN; BUCLIZINE; CHLORPROMAZINE; CORTICOSTEROID; CYANOCOBALAMIN; CYCLIZINE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOXYLAMINE; DROPERIDOL; GINGER EXTRACT; HERBACEOUS AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; MECLOZINE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MULTIVITAMIN; ONDANSETRON; PHENOTHIAZINE DERIVATIVE; PLACEBO; PROCHLORPERAZINE MALEATE; PROMETHAZINE; PROTON PUMP INHIBITOR; PYRIDOXINE; SEROTONIN 3 ANTAGONIST; UNINDEXED DRUG;

ABSENCE OF SIDE EFFECTS; ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; CLEFT LIP PALATE; CLINICAL TRIAL; COST CONTROL; DIAGNOSTIC IMAGING; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REGIMEN; FETUS MALFORMATION; GASTROINTESTINAL REFLUX; GINGER; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE; MEDICAL DECISION MAKING; NAUSEA AND VOMITING; OUTPATIENT CARE; PATHOGENESIS; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY TERMINATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; QUALITY OF LIFE; REHYDRATION; REVIEW; TERATOGENICITY; THYROID FUNCTION TEST;

EID: 33646073999     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539505001701     Document Type: Review

References (116)

1. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 1987; 156: 1137-141.
2. Evans AJ, Li TC, Selby C, Jeffcoate WJ. Morning sickness and thyroid function. Br J Obstet Gynaecol 1986; 93: 520-22.
3. Shulman A, Shapiro MS, Bahary C, Shenkman L. Abnormal thyroid function in hyperemesis gravidarum. Acta Obstet Gynecol Scand 1989; 68: 533-36.
4. Wilson R, McKillop JH, MacLean M, Walker JJ, Fraser WD, Gray C et al. Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf) 1992; 37: 331-34.
5. Koch KL, Stern RM, Vasey M, Botti JJ, Creasy GW, Dwyer A. Gastric dysrhythmias and nausea of pregnancy. Dig Dis Sci 1990; 35: 961-68.
6. Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynaecol 1995; 102: 6-8.
7. Verberg MF, Gillott DJ, Al Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005; 11: 527-39.
8. Magee LA, Chandra K, Mazzotta P, Stewart D, Koren G, Guyatt GH. Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S232-S238.
9. Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S256-S261.
10. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs 2000; 59: 781-800.
11. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993; 43: 245-48.
12. Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol 2000; 182: 931-37.
13. Berker B, Soylemez F, Cengiz SD, Kose SK. Serologic assay of Helicobacter pylori infection. Is it useful in hyperemesis gravidarum? J Reprod Med 2003; 48: 809-12.
14. Jacobson GF, Autry AM, Somer-Shely TL, Pieper KL, Kirby RS. Helicobacter pylori seropositivity and hyperemesis gravidarum. J Reprod Med 2003; 48: 578-82.
15. Lee RH, Pan VL, Wing DA. The prevalence of Helicobacter pylori in the Hispanic population affected by hyperemesis gravidarum. Am J Obstet Gynecol 2005; 193: 1024-1027.
16. Hershman JM. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid 1999; 9: 653-57.
17. Rodien P, Bremont C, Sanson ML, Parma J, Van SJ, Costagliola S et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998; 339: 1823-826.
18. Leunen M, Velkeniers B, Verlaenen H. Is there a relationship between hyperemesis gravidarum and hyperthyroidism?. Acta Clin Belg 2001; 56: 78-85.
19. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992; 167: 648-52.
20. Tan JY, Loh KC, Yeo GS, Chee YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002; 109: 683-88.
21. Abdel-Hadi AH, Rodriguez-Lafora BM, Cantarero GA. [Wernicke's encephalopathy as a complication of hyperemesis gravidarum]. An Med Interna 2004; 21: 46-47.
22. Ferdinands MD, Seneviratne J, White O. Visual deterioration in hyperemesis gravidarum. Med J Aust 2005; 182: 585-86.
23. Ohara N, Narita F, Kayama C, Goto Y. Wernicke's encephalopathy associated with hyperemesis gravidarum. Hosp Med 2003; 64: 371.
24. Rabenda-Lacka K, Wilczynski J, Breborowicz GH, Lesniak P, Jurga S, Radoch Z. Wernicke's encephalopathy due to hyperemesis gravidarum. Ginekol Pol 2003; 74: 633-37.
25. Spruill SC, Kuller JA. Hyperemesis gravidarum complicated by Wernicke's encephalopathy. Obstet Gynecol 2002; 99: 875-77.
26. Rhodes VA, Watson PM, Johnson MH. Development of reliable and valid measures of nausea and vomiting. Cancer Nurs 1984; 7: 33-41.
27. O'Brien B, Naber S. Nausea and vomiting during pregnancy: effects on the quality of women's lives. Birth 1992; 19: 138-43.
28. Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol 2000; 21: 129-36.
29. Vellacott ID, Cooke EJ, James CE. Nausea and vomiting in early pregnancy. Int J Gynaecol Obstet 1988; 27: 57-62.
30. Attard CL, Kohli MA, Coleman S, Bradley C, Hux M, Atanackovic G. et al The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S220-S227.
31. Miller F. Nausea and vomiting in pregnancy: the problem of perception-is it really a disease? Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S182-S183.
32. Mazzotta P, Stewart DE, Koren G, Magee LA. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol 2001; 22: 7-12.
33. Tylden E. Hyperemesis and physiological vomiting. J Psychosom Res 1968; 12: 86-93.
34. Boneva RS, Moore CA, Botto L, Wong LY, Erickson JD. Nausea during pregnancy and congenital heart defects: a population-based case-control study. Am J Epidemiol 1999; 149: 717-25.
35. Vohra S, Koren G. Hypothetical framework for a relationship between maternal thyroid function, nausea and vomiting of pregnancy, and congenital heart disease. Med Hypotheses 2001; 56: 392-94.
36. Boskovic R, Rudic N, nieliewska-Nikiel B, Navioz Y, Koren G. Is lack of morning sickness teratogenic? A prospective controlled study. Birth Defects Res Part A Clin Mol Teratol 2004; 70: 528-30.
37. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002; 186 (5 Suppl Understanding): S228-S231.
38. Koren G. Appraisal of drug therapy for nausea and vomiting of pregnancy: I. The placebo effect - methodological and practical considerations. Can J Clin Pharmacol 2000; 7: 135-37.
39. Chandra K, Magee L, Einarson A, Koren G. Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. J Psychosom Obstet Gynaecol 2003; 24: 71-75.
40. Tiran D. Nausea and vomiting in pregnancy: safety and efficacy of self-administered complementary therapies. Complement Ther Nurs Midwifery 2002; 8: 191-96.
41. Hollyer T, Boon H, Georgousis A, Smith M, Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy. BMC Complement Altern Med 2002; 2: 5.
42. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246-52.
43. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van RM et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-575.
44. Allaire AD, Moos MK, Wells SR. Complementary and alternative medicine in pregnancy: a survey of North Carolina certified nurse-midwives. Obstet Gynecol 2000; 95: 19-23.
45. Carlsson CP, Axemo P, Bodin A, Carstensen H, Ehrenroth B, Madegard-Lind I et al. Manual acupuncture reduces hyperemesis gravidarum: a placebo-controlled, randomized, single-blind, crossover study. J Pain Symptom Manage 2000; 20: 273-79.
46. Knight B, Mudge C, Openshaw S, White A, Hart A. Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial. Obstet Gynecol 2001; 97: 184-88.
47. Werntoft E, Dykes AK. Effect of acupressure on nausea and vomiting during pregnancy. A randomized, placebo-controlled, pilot study. J Repiod Med 2001; 46: 835-39.
48. Broussard CN, Richter JE. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 1998; 27: 123-51.
49. Stainton MC, Neff EJ. The efficacy of SeaBands for the control of nausea and vomiting in pregnancy. Health Care Women Int 1994; 15: 563-75.
50. Portnoi G, Chng LA, Karimi-Tabesh L, Koren G, Tan MP, Einarson A. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 2003; 189: 1374-377.
51. Fischer-Rasmussen W, Kjaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 1991; 38: 19-24.
52. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol 2001; 97: 577-82.
53. Smith C, Crowther C, Willson K, Hotham N, McMillian V. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol 2004; 103: 639-45.
54. Sripramote M, Lekhyananda N. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J Med Assoc Thai 2003; 86: 846-53.
55. Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol 1991; 78: 33-36.
56. Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1995; 173: 881-84.
57. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-51.
58. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2003; (4):CD000145.
59. Habek D, Barbir A, Habek JC, Janculiak D, Bobic-Vukovic M. Success of acupuncture and acupressure of the Pc 6 acupoint in the treatment of hyperemesis gravidarum. Forsch Komplementarmed Klass Naturheilkd 2004; 11: 20-23.
60. Markose MT, Ramanathan K, Vijayakumar J. Reduction of nausea, vomiting, and dry retches with P6 acupressure during pregnancy. Int J Gynaecol Obstet 2004; 85: 168-69.
61. Norheim AJ, Pedersen EJ, Fonnebo V, Berge L. Acupressure treatment of morning sickness in pregnancy. A randomised, double-blind, placebo-controlled study. Scand J Prim Health Care 2001; 19: 43-17.
62. Johnson DR, Douglas D, Hauswald M, Tandberg D. Dehydration and orthostatic vital signs in women with hyperemesis gravidarum. Acad Emerg Med 1995; 2: 692-97.
63. Van Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol 1995; 172: 1585-591.
64. Gulley RM, Vander PN, Gulley JM. Treatment of hyperemesis gravidarum with nasogastric feeding. Nutr Clin Pract 1993; 8: 33-35.
65. Hsu JJ, Clark-Glena R, Nelson DK, Kim CH. Nasogastric enteral feeding in the management of hyperemesis gravidarum. Obstet Gynecol 1996; 88: 343-46.
66. Vaisman N, Kaidar R, Levin I, Lessing JB. Nasojejunal feeding in hyperemesis gravidarum - a preliminary study. Clin Nutr 2004; 23: 53-57.
67. Erick M. Nutrition via jejunostomy in refractory hyperemesis gravidarum: a case report. J Am Diet Assoc 1997; 97: 1154-156.
68. Godil A, Chen YK. Percutaneous endoscopic gastrostomy for nutrition support in pregnancy associated with hyperemesis gravidarum and anorexia nervosa. J Parenter Enteral Nutr 1998; 22: 238-41.
69. Levine MG, Esser D. Total parenteral nutrition for the treatment of severe hyperemesis gravidarum: maternal nutritional effects and fetal outcome. Obstet Gynecol 1988; 72: 102-107.
70. Stellato TA, Danziger LH, Burkons D. Fetal salvage with maternal total parenteral nutrition: the pregnant mother as her own control. J Parenter Enteral Nutr 1988; 12: 412-13.
71. Subramaniam R, Soh EB, Dhillon HK, Abidin HZ. Total parenteral nutrition (TPN) and steroid usage in the management of hyperemesis gravidarum. Aust N Z J Obstet Gynaecol 1998; 38: 339-41.
72. Wiedner LC, Fish J, Talabiska DG, Jensen GL. Total parenteral nutrition in pregnant patient with hyperemesis gravidarum. Nutrition 1993; 9: 446-50.
73. Folk J, Leslie-Brown H, Nosovitch J, Silverman R, Aubry R. Hyperemesis gravidarum: outcomes and complications with and without total parenteral nutrition. Nutr Clin Pract 2005; 20: 364-65.
74. Folk JJ, Leslie-Brown HF, Nosovitch JT, Silverman RK, Aubry RH. Hyperemesis gravidarum: outcomes and complications with and without total parenteral nutrition. J Reprod Med 2004; 49: 497-502.
75. Greenspoon JS, Masaki DI, Kurz CR. Cardiac tamponade in pregnancy during central hyperalimentation. Obstet Gynecol 1989; 73: 465-66.
76. Hoff SD, Rowlands BJ. Guillain-Barre syndrome due to hypophosphatemia following intravenous hyperalimentation. J Parenter Enteral Nutr 1988; 12: 414-16.
77. Sakai M, Yoneda S, Sasaki Y, Saito S. Maternal total parenteral nutrition and fetal subdural hematoma. Obstet Gynecol 2003; 101: 1142-144.
78. Atanackovic G, Wolpin J, Koren G. Determinants of the need for hospital care among women with nausea and vomiting of pregnancy. Clin Invest Med 2001; 24: 90-93.
79. Lombardi DG, Istwan NB, Rhea DJ, O'Brien JM, Barton JR. Measuring outpatient outcomes of emesis and nausea management in pregnant women. Manag Care 2004; 13: 48-52.
80. Buttino L, Jr., Coleman SK, Bergauer NK, Gambon C, Stanziano GJ. Home subcutaneous metoclopramide therapy for hyperemesis gravidarum. J Perinatol 2000; 20: 359-362.
81. Naef RW, III, Chauhan SP, Roach H, Roberts WE, Travis KH, Morrison JC. Treatment for hyperemesis gravidarum in the home: an alternative to hospitalization. J Perinatol 1995; 15: 289-92.
82. Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G. The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod Toxicol 1999; 13: 313-19.
83. Baggley A, Navioz Y, Maltepe C, Koren G, Einarson A. Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. J Midwifery Womens Health 2004; 49: 350-54.
84. Levichek Z, Atanackovic G, Oepkes D, Maltepe C, Einarson A, Magee L et al. Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can Fam Physician 2002; 48: 267-8, 277.
85. Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997; 78: 157-159.
86. Seto A, Einarson T, Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 1997; 14: 119-24.
87. McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology 1994; 50: 27-37.
88. Kutcher JS, Engle A, Firth J, Lamm SH. Bendectin and birth defects. II: Ecological analyses. Birth Defects Res A Clin Mol Teratol 2003; 67: 88-97.
89. Geiger CJ, Fahrenbach DM, Healey FJ. Bendectin in the treatment of nausea and vomiting in pregnancy. Obstet Gynecol 1959; 14: 688-90.
90. Boskovic R, Einarson A, Maltepe C, Wolpin J, Koren G. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J Obstet Gynaecol Can 2003; 25: 830-33.
91. Atanackovic G, Navioz Y, Moretti ME, Koren G. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy. J Clin Pharmacol 2001; 41: 842-45.
92. Koren G, Maltepe C. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol 2004; 24: 530-33.
93. Einarson A, Koren G, Bergman U. Nausea and vomiting in pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol 1998; 76: 1-3.
94. Greenberg G, Inman WH, Weatherall JA, Adelstein AM, Haskey JC. Maternal drug histories and congenital abnormalities. Br Med J 1977; 2: 853-56.
95. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971; 1 (5748): 523-527.
96. Rumeau-Rouquette C, Goujard J, Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratology 1977; 15: 57-64.
97. Nageotte MP, Briggs GG, Towers CV, Asrat T. Droperidol and diphenhydramine in the management of hyperemesis gravidarum. Am J Obstet Gynecol 1996; 174: 1801-805.
98. Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, Schuler-Faccini L et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol 2002; 19: 311-16.
99. Fitzgerald JP. The effect of promethazine in nausea and vomiting of pregnancy. N Z Med J 1955; 54: 215-18.
100. Lask S. Treatment of nausea and vomiting of pregnancy with antihistamines. Br Med 1953; 1: 652-53.
101. Newlinds JS. Nausea and vomiting in pregnancy: A trial of thiethylperazine. Med J Aust 1964; 14: 234-36.
102. Bsat FA, Hoffman DE, Seubert DE. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003; 23: 531-35.
103. Guikontes E, Spantideas A, Diakakis J. Ondansetron and hyperemesis gravidarum. Lancet 1992; 340: 1223.
104. Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J 1996; 72: 688-89.
105. World MJ. Ondansetron and hyperemesis gravidarum. Lancet 1993; 341: 185.
106. Sullivan CA, Johnson CA, Roach H, Martin RW, Stewart DK, Morrison JC. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Am J Obstet Gynecol 1996; 174: 1565-568.
107. Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111: 940-43.
108. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-92.
109. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewel V et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148-53.
110. Ylikorkala O, Kauppila A, Ollanketo ML. Intramuscular ACTH or placebo in the treatment of hyperemesis gravidarum. Acta Obstet Gynecol Scand 1979; 58: 453-55.
111. Safari HR, Fassett MJ, Souter IC, Alsulyman OM, Goodwin TM. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol 1998; 179: 921-24.
112. Yost NP, McIntire DD, Wians FH Jr., Ramin SM, Balko JA, Leveno KJ. A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol 2003; 102: 1250-254.
113. Nelson-Piercy C, Fayers P, de SM. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG 2001; 108: 9-15.
114. Ziaei S, Hosseiney FS, Faghihzadeh S. The efficacy low dose of prednisolone in the treatment of hyperemesis gravidarum. Acta Obstet Gynecol Scand 2004; 83: 272-75.
115. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998; 105: 877-81.
116. Lalkin A, Magee L, Addis A, Loebstein R, Koren G. Acid-suppressing drugs during pregnancy. Can Fam Physician 1997; 43: 1923-4, 1926.